Repligen Stock Technical Analysis

RGEN Stock  USD 142.18  2.52  1.80%   
As of the 7th of February, Repligen holds the Coefficient Of Variation of (3,620), risk adjusted performance of (0.02), and Variance of 4.68. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them.

Repligen Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Repligen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RepligenRepligen's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Repligen Analyst Consensus

Target PriceConsensus# of Analysts
190.89Strong Buy19Odds
Repligen current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Repligen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Repligen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Repligen, talking to its executives and customers, or listening to Repligen conference calls.
Repligen Analyst Advice Details
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.6
Earnings Share
0.01
Revenue Per Share
12.602
Quarterly Revenue Growth
0.219
Return On Assets
0.013
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.

Repligen 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Repligen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Repligen.
0.00
11/09/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/07/2026
0.00
If you would invest  0.00  in Repligen on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Repligen or generate 0.0% return on investment in Repligen over 90 days. Repligen is related to or competes with Avantor, Masimo, Baxter International, AptarGroup, Bio Rad, DaVita HealthCare, and Charles River. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manuf... More

Repligen Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Repligen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Repligen upside and downside potential and time the market with a certain degree of confidence.

Repligen Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Repligen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Repligen's standard deviation. In reality, there are many statistical measures that can use Repligen historical prices to predict the future Repligen's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Repligen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
139.96142.17144.38
Details
Intrinsic
Valuation
LowRealHigh
127.96146.63148.84
Details
Naive
Forecast
LowNextHigh
131.87134.07136.28
Details
19 Analysts
Consensus
LowTargetHigh
173.71190.89211.89
Details

Repligen February 7, 2026 Technical Indicators

Repligen Backtested Returns

Repligen maintains Sharpe Ratio (i.e., Efficiency) of close to zero, which implies the firm had a close to zero % return per unit of risk over the last 3 months. Repligen exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Repligen's Coefficient Of Variation of (3,620), variance of 4.68, and Risk Adjusted Performance of (0.02) to confirm the risk estimate we provide. The company holds a Beta of 1.48, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Repligen will likely underperform. At this point, Repligen has a negative expected return of -0.0157%. Please make sure to check Repligen's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Repligen performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.06  

Very weak reverse predictability

Repligen has very weak reverse predictability. Overlapping area represents the amount of predictability between Repligen time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Repligen price movement. The serial correlation of -0.06 indicates that barely 6.0% of current Repligen price fluctuation can be explain by its past prices.
Correlation Coefficient-0.06
Spearman Rank Test-0.57
Residual Average0.0
Price Variance69.65
Repligen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Repligen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Repligen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Repligen Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Repligen volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Repligen Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Repligen on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Repligen based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Repligen price pattern first instead of the macroeconomic environment surrounding Repligen. By analyzing Repligen's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Repligen's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Repligen specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Days Sales Outstanding71.6777.1669.4446.5
PTB Ratio5.14.083.672.9

Repligen February 7, 2026 Technical Indicators

Most technical analysis of Repligen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Repligen from various momentum indicators to cycle indicators. When you analyze Repligen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Repligen February 7, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Repligen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.6
Earnings Share
0.01
Revenue Per Share
12.602
Quarterly Revenue Growth
0.219
Return On Assets
0.013
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.